Le Lézard46m
U.S. FDA Grants Full Approval of Deciphera's ROMVIMZAtm (vimseltinib) for the Treatment of Symptomatic Tenosynovial Giant Cell Tumor (TGCT)
Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Toichi Takino; "Ono") announced that the U.S. Food and Drug Administration (FDA) has approved ROMVIMZAtm (vimseltinib), a kinase ...
Too Old to Operate11h
Steatotic Liver Disease Subtypes and Colorectal Cancer Risk
The following is a summary of "Colorectal cancer incidence in steatotic liver disease (MASLD, MetALD, and ALD)," published in ...
Doctor says two stomach symptoms could signal liver damage
Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...
I'm a doctor - these four symptoms could mean you have liver damage
Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...
emjreviews.com9h
Clinical Complete Response a New Prognostic Marker in Liver Cancer
CLINICAL complete response (cCR) is a strong predictor of prognosis in patients with unresectable hepatocellular carcinoma ...